Strong Alterations in the Sphingolipid Profile of Chickens Fed a Dose of Fumonisins Considered Safe

Fumonisins (FB) are mycotoxins known to exert most of their toxicity by blocking ceramide synthase, resulting in disruption of sphingolipid metabolism. Although the effects of FB on sphinganine (Sa) and sphingosine (So) are well documented in poultry, little information is available on their other effects on sphingolipids. The objective of this study was to analyze the effects of FB on the hepatic and plasma sphingolipidome in chickens. The first concern of this analysis was to clarify the effects of FB on hepatic sphingolipid levels, whose variations can lead to numerous toxic manifestations. The second was to specify the possible use of an alteration of the sphingolipidome as a biomarker of exposure to FB, in addition to the measurement of the Sa:So ratio already widely used. For this purpose, we developed an UHPLC MS/MS method that enabled the determination of 82 SL, including 10 internal standards, in chicken liver and plasma. The validated method was used to measure the effects of FB administered to chickens at a dose close to 20 mg FB1 + FB2/kg feed for 9 days. Significant alterations of sphingoid bases, ceramides, dihydroceramides, glycosylceramides, sphingomyelins and dihydrosphingomyelins were observed in the liver. In addition, significant increases in plasma sphinganine 1-phosphate, sphingosine 1-phosphate and sphingomyelins were observed in plasma. Interestingly, partial least-squares discriminant analysis of 11 SL in plasma made it possible to discriminate exposed chickens from control chickens, whereas analysis of Sa and So alone revealed no difference. In conclusion, our results show that the effects of FB in chickens are complex, and that SL profiling enables the detection of exposure to FB when Sa and So fail.

[1]  P. Guerre,et al.  Fumonisin B1 Accumulates in Chicken Tissues over Time and This Accumulation Was Reduced by Feeding Algo-Clay , 2021, Toxins.

[2]  M. Scippo,et al.  Mycotoxins in Poultry Feed and Feed Ingredients from Sub-Saharan Africa and Their Impact on the Production of Broiler and Layer Chickens: A Review , 2021, Toxins.

[3]  M. Long,et al.  Research Progress on Fumonisin B1 Contamination and Toxicity: A Review , 2021, Molecules.

[4]  T. Varzakas,et al.  Advances in Occurrence, Importance, and Mycotoxin Control Strategies: Prevention and Detoxification in Foods , 2020, Foods.

[5]  Hui Chen,et al.  Molecular mechanisms of fumonisin B1-induced toxicities and its applications in the mechanism-based interventions. , 2019, Toxicon : official journal of the International Society on Toxinology.

[6]  P. Froment,et al.  Lack of Toxic Interaction between Fusariotoxins in Broiler Chickens Fed throughout Their Life at the Highest Level Tolerated in the European Union , 2019, Toxins.

[7]  A. Merrill,et al.  Ceramide synthase inhibition by fumonisins: a perfect storm of perturbed sphingolipid metabolism, signaling, and disease[S] , 2019, Journal of Lipid Research.

[8]  G. Galaverna,et al.  Mechanisms of Fumonisin B1 Toxicity: A Computational Perspective beyond the Ceramide Synthases Inhibition. , 2018, Chemical research in toxicology.

[9]  Suquan Song,et al.  Mycotoxins in commercial dry pet food in China , 2018, Food additives & contaminants. Part B, Surveillance.

[10]  Heather M. Wallace,et al.  Risks for animal health related to the presence of fumonisins, their modified forms and hidden forms in feed , 2018, EFSA journal. European Food Safety Authority.

[11]  S. Gibson,et al.  An LC/MS/MS method for the simultaneous determination of individual sphingolipid species in B cells. , 2016, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[12]  M. Parnham,et al.  The enigma of ceramide synthase regulation in mammalian cells. , 2016, Progress in lipid research.

[13]  S. Gregory,et al.  Evidence for fumonisin inhibition of ceramide synthase in humans consuming maize-based foods and living in high exposure communities in Guatemala. , 2015, Molecular nutrition & food research.

[14]  S. Gregory,et al.  A blood spot method for detecting fumonisin-induced changes in putative sphingolipid biomarkers in LM/Bc mice and humans , 2015, Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment.

[15]  Huidong Gu,et al.  Selecting the correct weighting factors for linear and quadratic calibration curves with least-squares regression algorithm in bioanalytical LC-MS/MS assays and impacts of using incorrect weighting factors on curve stability, data quality, and assay performance. , 2014, Analytical chemistry.

[16]  H. Guillou,et al.  New insights into the organ-specific adverse effects of fumonisin B1: comparison between lung and liver , 2014, Archives of Toxicology.

[17]  P. Hu,et al.  Improved sphingolipidomic approach based on ultra-high performance liquid chromatography and multiple mass spectrometries with application to cellular neurotoxicity. , 2014, Analytical chemistry.

[18]  J. Schlatter,et al.  WHO FOOD ADDITIVES SERIES : 58 Safety evaluation of certain food additives and contaminants , 2014 .

[19]  Gerd Geisslinger,et al.  Chain length-specific properties of ceramides. , 2012, Progress in lipid research.

[20]  Liana C. Silva,et al.  A Critical Role for Ceramide Synthase 2 in Liver Homeostasis , 2010, The Journal of Biological Chemistry.

[21]  Jeremy C. Allegood,et al.  Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers[S] , 2009, Journal of Lipid Research.

[22]  A. Merrill,et al.  Ceramide Synthase Inhibition by Fumonisin B 1 Causes Accumulation of 1-Deoxysphinganine A NOVEL CATEGORY OF BIOACTIVE 1-DEOXYSPHINGOID BASES AND 1-DEOXYDIHYDROCERAMIDES BIOSYNTHESIZED BY MAMMALIAN CELL LINES AND ANIMALS * , 2009 .

[23]  W. Haschek,et al.  Fumonisins : Toxicokinetics, mechanism of action and toxicity , 2007 .

[24]  P. Guerre,et al.  Effects of fumonisins on liver and kidney sphinganine and the sphinganine to sphingosine ratio during chronic exposure in ducks. , 2006, Chemico-biological interactions.

[25]  P. Guerre,et al.  Serum sphinganine and the sphinganine to sphingosine ratio as a biomarker of dietary fumonisins during chronic exposure in ducks. , 2006, Chemico-biological interactions.

[26]  Hiroyuki Tsuda,et al.  WORLD HEALTH ORGANIZATION INTERNATIONAL AGENCY FOR RESEARCH ON CANCER IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 2005 .

[27]  W. Marasas,et al.  The implications of naturally occurring levels of fumonisins in corn for human and animal health , 1992, Mycopathologia.

[28]  P. Guerre,et al.  Sphinganine to sphingosine ratio and predictive biochemical markers of fumonisin B1 exposure in ducks. , 2003, Chemico-biological interactions.

[29]  P. Howard,et al.  Fumonisin b1 carcinogenicity in a two-year feeding study using F344 rats and B6C3F1 mice. , 2001, Environmental health perspectives.

[30]  N. Skovgaard.  Safety evaluation of certain food additives and contaminants , 2000 .

[31]  H. Boermans,et al.  Fumonisin toxicosis in domestic animals: a review. , 1994, Veterinary and human toxicology.

[32]  A. Merrill,et al.  Alteration of tissue and serum sphinganine to sphingosine ratio: an early biomarker of exposure to fumonisin-containing feeds in pigs. , 1993, Toxicology and applied pharmacology.

[33]  H. Yoo,et al.  Fumonisin inhibition of de novo sphingolipid biosynthesis and cytotoxicity are correlated in LLC-PK1 cells. , 1992, Toxicology and applied pharmacology.

[34]  A. Merrill,et al.  Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. , 1991, The Journal of biological chemistry.